To study the beneficial effects of dexmedetomidine drug by adding to lignocaine nebulization in patients undergoing general anesthesia for better outcome.
Phase 4
- Conditions
- Health Condition 1: V299- Motorcycle rider (driver) (passenger) injured in unspecified traffic accident
- Registration Number
- CTRI/2024/05/067063
- Lead Sponsor
- Dr T G KHAAR MUGILA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients scheduled to undergo elective surgeries under general anesthesia.
2.Patients of ASA physical status I&II.
3.Patients of either sex.
4.Age 18 to 60 years.
5.Body Mass Index 18 to 35 kg/m2.
Exclusion Criteria
1.Patients with difficult airway.
2.Pregnant/Lactating Women.
3.Severe mental illness, or Cognitive dysfunction (unable to communicate or cooperate)
4.Patients with thrombocytopenia or coagulopathy.
5.Patients with nasal polyps, history of
previous nasal surgery/nasal trauma.
6.Patients allergic to the drugs involved in the
study.
7.Patients refusal for participation in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To Estimate and compare mean intubation time in Lignocaine Nebulization and Lignocaine with Dexmedetomidine Nebulization for Awake Fiberoptic IntubationTimepoint: Seconds (during intubation)
- Secondary Outcome Measures
Name Time Method 1.To Estimate and compare hemodynamic changes and level of sedation in both groups <br/ ><br>2.To Assess and compare intubation condition, vocal cord position, cough severity, patient tolerance and postoperative patient satisfaction in both groupsTimepoint: 1,2,3,5,10,20Minutes